Skip to search formSkip to main contentSkip to account menu

S 33005

Known as: S33005 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2009
2009
Discriminative stimulus properties of the “atypical” antidepressant, mirtazapine, in rats: a pharmacological characterization
RationaleThough interoceptive properties of antidepressants have been described, discriminative stimulus (DS) properties of… 
2007
2007
Discriminative stimulus properties of the selective norepinephrine reuptake inhibitor, reboxetine, in rats: a characterization with alpha/beta-adrenoceptor subtype selective ligands, antidepressants…
Although little information is available concerning discriminative stimulus (DS) properties of antidepressants, rats can be… 
2005
2005
Acute administration of the novel serotonin and noradrenaline reuptake inhibitor, S33005, markedly modifies sleep–wake cycle architecture in the rat
RationaleThe interrelationship between depressive states and sleep–wake cycle architecture is characterised by a decreased… 
2004
2004
The novel monoamine reuptake inhibitor and potential antidepressant, S33005, induces Arc gene expression in cerebral cortex.
2004
2004
The novel monoamine reuptake inhibitor and potential antidepressant, S33005, induces Arc gene expression in cerebral cortex.
Recent data show that corticolimbic expression of the effector immediate early gene Arc is up-regulated by standard… 
2004
2004
Erratum: The novel monoamine reuptake inhibitor and potential antidepressant, S33005, induces Arc gene expression in cerebral cortex (European Journal of Pharmacology (2004) 489 (179-185) DOI: 10…
Highly Cited
2002
Highly Cited
2002
Induction of hyperlocomotion in mice exposed to a novel environment by inhibition of serotonin reuptake A pharmacological characterization of diverse classes of antidepressant agents
2002
2002
Differential modulation of efficiency in a food-rewarded "differential reinforcement of low-rate" 72-s schedule in rats by norepinephrine and serotonin reuptake inhibitors
HeadingAbstract Rationale. The differential reinforcement of low-rate 72-s (DRL 72-s) schedule, in which rats must withhold a… 
Highly Cited
2001
Highly Cited
2001
S33005, a novel ligand at both serotonin and norepinephrine transporters: I. Receptor binding, electrophysiological, and neurochemical profile in comparison with venlafaxine, reboxetine, citalopram…
S33005 displayed marked affinity for native, rat, and cloned human serotonin (5-HT) transporters (SERT) and less pronounced… 
Highly Cited
2001
Highly Cited
2001
S33005, a novel ligand at both serotonin and norepinephrine transporters: II. Behavioral profile in comparison with venlafaxine, reboxetine, citalopram, and clomipramine.
Reflecting its potent inhibition of serotonin (5-HT) reuptake (accompanying paper), S33005 blocked spontaneous tail-flicks… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)